American Healthcare REIT, Inc. (NYSE:AHR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of American Healthcare REIT, Inc. (NYSE:AHR) have been given an average recommendation of “Moderate Buy” by the eight brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $20.38.

A number of brokerages have recently issued reports on AHR. Bank of America increased their price objective on shares of American Healthcare REIT from $19.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Truist Financial increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. JMP Securities boosted their price objective on American Healthcare REIT from $16.00 to $18.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 7th. Morgan Stanley increased their target price on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. Finally, KeyCorp lifted their target price on American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday.

American Healthcare REIT Stock Up 3.6 %

NYSE AHR opened at $25.41 on Friday. American Healthcare REIT has a 1-year low of $12.63 and a 1-year high of $25.92. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. The business’s fifty day moving average price is $19.24 and its 200-day moving average price is $15.97.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.28). American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The business had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $506.55 million. American Healthcare REIT’s revenue for the quarter was up 7.9% compared to the same quarter last year. As a group, research analysts anticipate that American Healthcare REIT will post 1.28 EPS for the current year.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, September 20th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 3.94%. The ex-dividend date is Friday, September 20th.

Institutional Trading of American Healthcare REIT

Large investors have recently added to or reduced their stakes in the company. Peak Financial Advisors LLC purchased a new position in shares of American Healthcare REIT in the first quarter valued at $416,000. Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of American Healthcare REIT in the 1st quarter worth about $7,694,000. Peregrine Capital Management LLC bought a new stake in shares of American Healthcare REIT in the 1st quarter worth about $7,763,000. Principal Financial Group Inc. purchased a new stake in shares of American Healthcare REIT during the 1st quarter valued at about $88,504,000. Finally, Capstone Investment Advisors LLC bought a new position in shares of American Healthcare REIT in the 1st quarter valued at about $1,201,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.